Short Interest in Aspira Women’s Health Inc. (NASDAQ:AWH) Rises By 28.0%

Aspira Women’s Health Inc. (NASDAQ:AWHGet Free Report) saw a large growth in short interest in the month of February. As of February 28th, there was short interest totalling 1,510,000 shares, a growth of 28.0% from the February 13th total of 1,180,000 shares. Based on an average trading volume of 301,100 shares, the days-to-cover ratio is presently 5.0 days. Currently, 12.0% of the shares of the company are sold short.

Analysts Set New Price Targets

Separately, StockNews.com assumed coverage on Aspira Women’s Health in a research note on Sunday, January 12th. They set a “hold” rating for the company.

Read Our Latest Stock Report on Aspira Women’s Health

Institutional Trading of Aspira Women’s Health

A hedge fund recently raised its stake in Aspira Women’s Health stock. B. Riley Wealth Advisors Inc. raised its holdings in Aspira Women’s Health Inc. (NASDAQ:AWHFree Report) by 33.8% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 316,294 shares of the company’s stock after acquiring an additional 79,898 shares during the period. B. Riley Wealth Advisors Inc. owned approximately 1.90% of Aspira Women’s Health worth $256,000 at the end of the most recent reporting period. 12.19% of the stock is owned by institutional investors and hedge funds.

Aspira Women’s Health Stock Performance

Shares of AWH opened at $0.14 on Monday. The stock’s 50-day simple moving average is $0.35 and its 200 day simple moving average is $0.66. The stock has a market capitalization of $2.47 million, a price-to-earnings ratio of -0.12 and a beta of 1.57. Aspira Women’s Health has a 52-week low of $0.12 and a 52-week high of $3.81.

About Aspira Women’s Health

(Get Free Report)

Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

Read More

Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with MarketBeat.com's FREE daily email newsletter.